Medisch Spectrum Twente — Clinical Trial Site

105 Registered trials

49 Currently recruiting

Organisation

Medisch Spectrum Twente

Location

Enschede, Netherlands

Identifier

ORG-100043548

Address

Koningsplein 1, 7512 KZ, Netherlands

Departments

#2923:Cardiology
#3704: Cardiology
2603: Cardiology
5002: Cardiology
Afd. Interne geneeskunde
Anesthesiology
Cardiology
chirurgie
Department E25 Oncology/ internal medicine
Department of Surgery
gastroenterology
Gastroenterology and Hepatology
Gynaecologic Oncology
Gynaecology
Haematology
Hematologie
Hematology
Hematology / Internal medicine
HPB surgery
ICU
Intensive care
Intensive Care Centrum
Internal Medicine
Internal medicine/haematology/oncology
interne geneeskunde
Kindergeneeskunde
Longgeneeskunde
Medical Oncology
medische oncologie
N/A
NA
Neurologie
Neurology
Neurosurgery
Obstetrics & Gynaeccology
Oncologie
Oncology
Otorhinolaryngology
pharmacy
Pulmonary Diseases
Pulmonary medicine
Pulmonary Science
Pulmonology
Research Faculty
Reumatologie
Rheumatology
Surgery
Thorax centrum Twente
Thoraxcentrum Twente

Clinical trials at this site (105)

Search interface

StAtins in Frail oldEr patients with ischemic Stroke or Transient ischemic attack – The Randomized Controlled Trial Recruiting

2024-517343-31-00 Ischemic stroke and transient ischemic attack 6 2025-04-11
Treatment of ELectroencephalographic STatus epilepticus After cardiopulmonary Resuscitation-2 (TELSTAR-2): a multicenter randomised clinical… Recruiting

2024-516068-27-01 cardiopulmonary resuscitation 5 2025-04-10
Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Subjects With Metastatic Colorectal Ca… Recruiting

2022-502352-31-00 Colorectal Cancer (CRC) 5 2025-02-10
A WORLD-WIDE CLINICAL STUDY TO FIND OUT IF INTRAVENOUS RECOMBINANT HUMAN PLASMA GELSOLIN IS SAFE AND IS BENEFICIAL FOR TREATING ACUTE RESPIR… Recruiting

2023-510109-16-00 Acute Respiratory Distress Syndrome (ARDS) Due to Pneum 4 2025-01-06
BuLLSEYE Recruiting

2024-512950-13-00 Sepsis 11 2025-01-03
Safe Stop Trial Melanoma Recruiting

2024-516937-10-01 Melanoma 5 2024-12-18
Stopping or continuing blood thinners after stroke at young age without a known cause: STOP trial Recruiting

2024-513092-40-00 Stroke 6 2024-12-05
Evaluating the safety of shortened infusion tiMes for dIfferent oNcological immUnoThErapies; An observational prospective study Recruiting

2024-518878-14-01 Inflammatory bowel disease 6 2024-11-25
The PREDMETH trial: Effectiveness of methotrexate versus prednisone as first-line therapy for pulmonary sarcoidosis – A randomized controlle… Recruiting

2024-514055-15-00 Pulmonary sarcoidosis 6 2024-11-19
Multicentre Randomized trial of Ghrelin in anterior circulation ischemic stroke treated with endovascular thrombectomy. A randomized phase 2… Recruiting

2024-515705-26-00 Stroke 4 2024-11-11
Timing of start of systemlc treatment for asymptomatic MEtastasized PANcreatic cancer (TIMEPAN): a prospective multicenter patient preferenc… Recruiting

2023-509465-20-00 metastatic pancreatic cancer 5 2024-10-28
DOSAgE study: A multicenter randomized phase III trial of DOSe-reduced Chemotherapy for Advanced Colorectal Cancer in Older patients Recruiting

2023-506115-17-00 Metastatic Colorectal Cancer 5 2024-10-14
Tranexamic acid to prevent OpeRation in Chronic subdural Hematoma (TORCH) Recruiting

2024-514927-40-02 Chronic Subdural Hematoma 11 2024-10-01
STOP-IMH Recruiting

2024-517783-37-00 ST elevation myocardial infarction (STEMI) 6 2024-09-20
Dose tapering and Early Discontinuation to InCreAse cosT-effictIveness Of immunotherapy for Non-small cell lung carcinoma trial number 1 (NV… Recruiting

2024-516195-15-00 Advanced NSCLC 5 2024-09-10
CLEAR-PATH trial Recruiting

2024-513363-15-01 (Chronic) Peripheral (occlusive) arterial disease (PAD) 11 2024-07-22
FeAsiBility of a treatment free interval in newly diagnosed mUltiple myeLOma patients treated with DaratumUmab-Lenalidomide-DexamethaSone – … Recruiting

2023-508586-33-00 multiple myeloma 5 2024-05-14
Metamizole as pain treatment in patients with chronic pancreatitis, a multicenter, randomized, double-blind, placebo-controlled, superiority… Recruiting

2023-504143-14-00 Chronic pancreatitis 6 2024-05-02
Phase 3 study to assess the efficacy and safety of Givinostat versus hydroxyurea in Polycythemia Vera patients Recruiting

2022-502276-23-00 JAK2V617F-positive high-risk Polycythemia Vera 5 2024-04-25
A Global Pivotal Placebo-Controlled Study of LY3537982 in Combination with Pembrolizumab and LY3537982 in Combination with Pembrolizumab, Pe… Recruiting

2023-503412-33-00 Stage IIIB-IIIC or Stage IV KRAS G12C-mutant non-small 5 2024-03-29
VulVaccin study Recruiting

2023-506792-94-00 Vulvar High-Grade Squamous Intraepithelial Lesion (vHSI 11 2024-03-04
Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients with Cardiogenic Shock f… Recruiting

2024-510892-40-00 Acute myocardial infarction complicated by cardiogenic 6 2024-02-29
Shortened 12 months duration of androgen receptor signalling agent in combination with androgen deprivation therapy in patients with low-vol… Recruiting

2023-506698-36-00 low-volume metastatic castration-sensitive prostate can 5 2024-02-02
A study to investigate the effect of adding cobicistat to venetoclax and azacitidine in patients with acute myeloid leukemia (AML) who are i… Recruiting

2023-505379-61-00 Acute Myeloid Leukaemia 4 2024-01-17